Part 3—Labelling requirements for primary packs, intermediate packaging and containers, Division 2—Labels on intermediate packaging · Therapeutic Goods (Standard for Labelling of Non-Prescription Medicines) (TGO 116) Order 2026

Contents

If the information required to be on the label on a container is obscured by intermediate packaging, the intermediate packaging must be labelled with all of the following information:

(a)the name of the medicine;

(b)the name of each active ingredient in the medicine;

(c)the quantity or proportion of each active ingredients in the medicine;

(d)the batch number, accompanied by the batch number identifier;

(e)the expiry date, accompanied by the expiry date identifier;

(f)the name of the sponsor, or a registered trade mark if it readily identifies the name of the sponsor of the medicine.

Sourced from the Federal Register of Legislation at legislation.gov.au, © Commonwealth of Australia, licensed under CC BY 4.0. Compilations may have been reformatted.

Therapeutic Goods (Standard for Labelling of Non-Prescription Medicines) (TGO 116) Order 2026

Division 2—Labels on intermediate packaging

14 Intermediate packaging #

Defined terms · 14

Key facts

History · 1 version

Division 2—Labels on intermediate packaging

14 Intermediate packaging #

Division 2—Labels on intermediate packaging

14 Intermediate packaging#

Defined terms · 14

Key facts

History · 1 version

Division 2—Labels on intermediate packaging

14 Intermediate packaging#

14 Intermediate packaging #

14 Intermediate packaging #